KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Cost of Revenue (2016 - 2025)

Boston Scientific (BSX) has disclosed Cost of Revenue for 17 consecutive years, with $6.2 billion as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 321.62% to $6.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.2 billion through Dec 2025, up 227.89% year-over-year, with the annual reading at $6.2 billion for FY2025, 18.34% up from the prior year.
  • Cost of Revenue hit $6.2 billion in Q4 2025 for Boston Scientific, up from $1.5 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $6.2 billion in Q4 2025 to a low of $9.0 million in Q2 2024.
  • Historically, Cost of Revenue has averaged $1.2 billion across 5 years, with a median of $975.5 million in 2021.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 33053.85% in 2023 and later plummeted 99.15% in 2024.
  • Year by year, Cost of Revenue stood at $972.0 million in 2021, then tumbled by 98.66% to $13.0 million in 2022, then surged by 33053.85% to $4.3 billion in 2023, then tumbled by 65.99% to $1.5 billion in 2024, then soared by 321.62% to $6.2 billion in 2025.
  • Business Quant data shows Cost of Revenue for BSX at $6.2 billion in Q4 2025, $1.5 billion in Q3 2025, and $14.0 million in Q2 2025.